From Materials Science to Surgical Vision Care

With more than 35 years of expertise in biomaterials and ophthalmic coatings, AST VisionCare transforms scientific heritage into advanced intraocular lens technology for modern cataract and phacorefractive surgery.

Brand overview

35 Years of Science Shaping the Future of Vision

Advanced biomaterials. Precision optics. Surgical performance.

  • 35+ years at the forefront of biocompatible materials and medical-grade coatings for ophthalmology.
  • A multidisciplinary team of physicists, chemists and biomaterials engineers, transforming scientific research into surgical solutions.
  • The Asqelio™ IOL platform is a convergence of scientific innovation, precision engineering and clinical application, delivering predictable outcomes and long-term safety.
  • In 2019, the AST VisionCare surgical division brought this expertise directly to surgeons worldwide.
  • 1989Biocompatible materials & medical-grade coatings for ophthalmology
  • 2017Asqelio™, our bi-aspheric intraocular lens platform
  • 2019AST VisionCare surgical division established
Values

What Guides Us

AST's values define how we think, act and communicate. They are operational, not aspirational. They guide decisions across science, design, communication and partnerships, ensuring consistency, credibility and long-term trust.

Scientific Integrity

All claims and communications are grounded in evidence and traceability.

Product Quality

Precision in materials, optics and manufacturing drives reliable outcomes.

Customer Centricity

Decisions are made with surgeons, teams and patients in mind.

Positioning

What We Offer

Intraocular lens solutions, surgical support and traceable clinical evidence, delivered as a long-term partnership beyond the procedure.

What We Deliver

  • Intraocular lens solutions for modern cataract and refractive needs.
  • Practical surgical support and training.
  • Clinical evidence and communication aligned with robust, traceable clinical data.
  • Long-term partnership beyond the initial procedure.

Reasons to Believe

  • Research-driven, bi-aspheric lens

    Designed to support predictability and optical quality.

  • Biomaterials & medical-grade coatings expertise

    Built on decades of research and development.

  • Fully integrated, 100% in-house

    End-to-end control across design, engineering, manufacturing and clinical support.

Global presence

Where We Are

A central office, production sites and distribution hubs spanning the Americas, Europe, the Middle East and Asia-Pacific.

AST VisionCare global presence, central office, production and distribution hubs across the Americas, Europe, the Middle East and Asia-Pacific
Responsibility & quality

Our Commitments

We align our priorities with the UN Sustainable Development Goals and build every Asqelio™ lens to the EU Medical Device Regulation.

SustainabilityAligned with the UN SDGs

EEnvironmental
12Responsible consumption and production
13Climate action
SSocial
3Good health and well-being
8Decent work and economic growth
GGovernance
17Partnerships for the goals

Quality & RegulatoryWhat the MDR Means for Us

The EU Medical Device Regulation (MDR 2017/745) sets a rigorous framework for the safety, performance and traceability of medical devices, every Asqelio™ lens is built to meet it.

  • CE-marked to MDR

    CE mark under MDR 2017/745 with complete technical documentation.

  • Clinical evaluation

    Backed by structured clinical evaluation and peer-reviewed evidence.

  • Post-market surveillance

    Ongoing monitoring and full traceability through the device lifecycle.